First-of-its-kind COVID-19 antibody treatment: FDA authorization requested | FDACDC
  • News
  • State of the COVID Nation
  • Blog
  • About Us
  • Contact Us
Home \ News \ First-of-its-kind COVID-19 antibody treatment: FDA authorization requested
More  
First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

NOW PLAYING
First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

CDC Statement on ACIP Booster Recommendations

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

Tense decision-making as CDC joins FDA in recommending Pfizer booster shot for 65 & up, people at high risk and those with occupational exposure to COVID-19

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

Ten scientific reasons in support of airborne transmission of SARS-CoV-2

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months, study shows

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

Top COVID-19 doctors and scientists privately asked the Biden administration to scrap its booster-shot plan, report says

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

Is my immunity waning? Doctors advise Pfizer vaccine recipients not to worry

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

FDA review finds Moderna’s booster dose of its coronavirus vaccine strengthens disease-fighting response

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

Myths and Facts about COVID-19 Vaccines

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

TENSE DECISION MAKING BETWEEN CDC AND FDA

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

FDACDC.com

Views
0
0
0
0 0
   
Share this with your friends via:     
   

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

TVNET3 November 2, 2021 4:02 pm

It could be the first long-acting antibody combination to receive an emergency authorization in the U.S. for COVID-19 prevention.

Category: News
About The Author
TVNET3 -
Previous

LIVE: FDA advisory panel to vote on J&J Covid booster shots — 10/15/2021

Next

CDC Statement on ACIP Booster Recommendations

Related Videos

FDA Panel Recommends J&J Booster Shot For Adults 18 And Over

FDA Panel Recommends J&J Booster Shot For Adults 18 And Over

FDACDC Phase4

Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months, study shows

FDACDC Phase2

Is my immunity waning? Doctors advise Pfizer vaccine recipients not to worry

FDACDC Phase4

TENSE DECISION MAKING BETWEEN CDC AND FDA

FDA panel recommends Pfizer vaccine for kids ages 5-11

FDA panel recommends Pfizer vaccine for kids ages 5-11

EH Nexus Webinar – September 14, 2021

EH Nexus Webinar – September 14, 2021


[ App Programmed TeleVision Engine ]  was developed by WRLD1 / TVNET as a scalable Mobile Netcast Architecture enabling Geocentric Networks across the 8 regions of the world.

Copyright 2021 WorldNetCast /TVNET

Web Solutions by Wirefreesoft | Google Partner

Visit Our Other Networks

Geo Regions | Global Focused News | http://georegions.com/

FDACDC - FDA CDC News
  • News
  • State of the COVID Nation
  • Blog
  • About Us
  • Contact Us
  • Close
  • News
  • State of the COVID Nation
  • Blog
  • About Us
  • Contact Us

Report Video

Please specify an ID for the Contact Form in Theme Options > Single Post/Video > Video Report Form